FGF2 and glycine encephalopathy: Notably, the development of GCE can trigger an elevation in cytokines, including CCL3, IL-12p70, IL-17, IL-17, IL-1ra, and bFGF, and altered levels of cytokines, including CCL11, HGF, and IL-18, can cause changes in GCE risk.